GM Advisory Group’s Teladoc Health TDOC Stock Holding History

GM Advisory Group’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,414	Closed	-$222K	–	218
2021 Q4	$222K	Sell	2,414 -8,645	-78%	-$1.03M	0.02%	186
2021 Q3	$1.4M	Buy	11,059 +744	+7%	+$108K	0.14%	74
2021 Q2	$1.72M	Buy	10,315 +4,900	+90%	+$794K	0.18%	75
2021 Q1	$984K	Buy	5,415 +50	+0.9%	+$11.6K	0.12%	85
2020 Q4	$1.07M	Sell	5,365 -2,348	-30%	-$477K	0.14%	66
2020 Q3	$1.69M	Buy	7,713 +460	+6%	+$97.4K	0.26%	47
2020 Q2	$1.38M	Sell	7,253 -4,666	-39%	-$818K	0.26%	53
2020 Q1	$1.85M	Buy	+11,919	New	+$1.39M	0.5%	34

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

GM Advisory Group's TDOC Position: Q1 2022 in Review

GM Advisory Group sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 2,414 shares — an estimated $222K sold.

GM Advisory Group first reported a position in TDOC in Q1 2020 and held it in 8 quarters. The position peaked at $1.85M in Q1 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

GM Advisory Group reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
GM Advisory Group sold 2,414 Teladoc Health shares in Q1 2022, an estimated $222K.
GM Advisory Group first reported a position in Teladoc Health in Q1 2020 and held it in 8 quarters.
GM Advisory Group's Teladoc Health position peaked at $1.85M in Q1 2020.
680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on GM Advisory Group's 13F filing for Q1 2022, filed 13 May 2022.